¨
2 A. Oztunc
pathway occurring by a 5-exo-mode is also followed in a
6-exo-mode
¸
, S. Imre, H. Lotter and H. Wagner, Phytochemistry,
1991, 30, 255–257.
3 (a) G. Guella, G. Chiasera, I. Mancini, A. Oztunc
Chem.–Eur. J., 1997, 3, 1223–1231; (b) M. L. Ciavatta, M.
Gavagnin, R. Puliti, G. Cimino, E. Martınez, J. Ortea and C. A.
Mattia, Tetrahedron, 1997, 53, 17343–17350.
4 D. C. Braddock, Org. Lett., 2006, 8, 6055–6058.
¨
¸
and F. Pietra,
We have also explored the intermolecular bromoetherifica-
tion reaction of an unfunctionalised enyne 25 with ethylene
glycol as a representative alcohol. To the best of our knowl-
edge this intermolecular reaction is unprecedented in the
literature. In preliminary experiments in dichloromethane
using 10 equivalents of added diol, although characteristic
bromoallene signals were observed in the 1H NMR spectrum,
a complex mixture of products were obtained, presumably as
the result of competitive intermolecular attack of a second
enyne on an incipient bromonium ion. In contrast using
ethylene glycol as the solvent (300 equivalents) gave rise to
bromoetherification with two diastereomeric bromoallenes 26
and 27*** isolated in 7 and 6% yield, respectively after
column chromatography (Scheme 7). A dibrominated adduct
28 (10%) was also isolated that must arise by initial attack of
the alcohol directly at the brominated alkyne of the enyne. The
relative ratio of 26 : 27 was essentially 1 : 1 by inspection of the
1H NMR spectrum of the crude product, showing that the
intermolecular bromoetherification reaction is not stereoselec-
tive under these conditions.
´
5 (a) A 23 : 19 ratio of bromoallenes was obtained in the cyclisation
of an E-enyne into laurallene: J. Ishihara, Y. Shimada, N. Kanoh,
Y. Takasugi, A. Fukuzawa and A. Murai, Tetrahedron, 1997, 53,
8371–8382; (b) a 2.5 : 1 ratio of bromoallenes was observed in the
cyclisation of an E-enyne in a biomimetic-type cyclisation for the
synthesis of (ꢀ)-kumausallene: P. A. Evans, V. S. Murthy, J. D.
Roseman and A. L. Rheingold, Angew. Chem., Int. Ed., 1999, 38,
3175–3177; (c) a 1 : 1 ratio of bromoallenes was obtained in the
cyclisation of an E-enyne into (+)-laurallene: M. T. Crimmins and
E. A. Tabet, J. Am. Chem. Soc., 2000, 122, 5473–5476; (d) a 1 : 1
ratio of bromoallenes was obtained in a biomimetic-type cyclisa-
tion of a Z-enyne for the synthesis of (ꢂ)-panacene: K. S. Feldman,
Tetrahedron Lett., 1982, 23, 3031–3034.
6 (a) E. Kurosawa, A. Fukuzawa and T. Irie, Tetrahedron Lett.,
1972, 13, 2121–2124; (b) laurencenyne and trans-laurencenyne have
also been suggested as early biosynthetic precursors to laurediol:
H. Kigoshi, Y. Shizuri, H. Niwa and K. Yamada, Tetrahedron
Lett., 1982, 23, 1475–1476, and references cited therein.
7 K. Nacro, M. Batas and L. Gorrichon, Tetrahedron, 1999, 55,
14013–14030.
8 F. Freeman, D. S. H. L. Kim and E. Rodrı
1992, 57, 1722–1727.
´
guez, J. Org. Chem.,
In conclusion, we have shown that an unperturbed intra-
molecular bromoetherification of an enyne proceeds by stereo-
selective syn addition. The inherent stereoselectivity is higher
than those observed to date in the cyclisation of enynes to
bromoallenes in more complex systems with pre-existing
stereocentres.5 Mechanistically we propose that a bromonium
ion is formed on the alkyne followed by nucleophilic attack of
the alcohol under stereoelectronic control. This is consistent
with the stereochemical outcome (syn) of the overall addition
of Br2 across a 1,3-diene where the participating orbital array
is essentially identical.19 The above findings represent funda-
mental stereochemical information with respect to electrophi-
lic 1,4-addition across an enyne. Moreover, it should guide the
choice of enyne geometry required in the synthesis of natural
products from Laurencia species. In particular it allows us
to target an E-enyne for the synthesis of obtusallenes
II and IV.20,21
9 M. Ahmed, G. C. Barley, M. T. W. Hearn, E. R. H. Jones, V.
Thaller and J. A. Yates, J. Chem. Soc., Perkin Trans. 1, 1974,
1981–1987.
10 J. R. Lakanen, A. E. Pegg and J. K. Coward, J. Med. Chem., 1995,
38, 2714–2727.
11 S. H. Kang and G. T. Kim, Tetrahedron Lett., 1995, 36, 5049–5052.
12 N. J. Harris and J. J. Gajewski, J. Am. Chem. Soc., 1994, 116,
6121–6129.
13 R. A. Karakhanov, M. M. Vartanyan, T. Yu. Solov’eva and L. F.
Lapuka, Khim. Geterot. Soed., 1983, 1602–1606.
14 T. A. Grese, K. D. Hutchinson and L. E. Overman, J. Org. Chem.,
1993, 58, 2468–2477.
15 C. J. Elsevier, P. Vermeer, A. Gedanken and W. Runge, J. Org.
Chem., 1985, 50, 364–367.
16 For recent applications of this method for the preparation of
naturally occurring bromoallenes, see: (a) J. Wang and B. L.
Pagenkopf, Org. Lett., 2007, 9, 3703–3706; (b) J. Park, B. Kim,
H. Kim, S. Kim and D. Kim, Angew. Chem., Int. Ed., 2007, 46,
4726–4728; (c) J. Boukouvalas, M. Pouliot, J. Robichaud, S.
MacNeil and V. Snieckus, Org. Lett., 2006, 8, 3597–3599.
17 E. Graf and J. M. Lehn, Helv. Chim. Acta, 1981, 64, 1040–1057.
18 D. B. Dess and J. C. Martin, J. Org. Chem., 1983, 48, 4155–4156.
19 G. E. Heasley, V. L. Heasley, S. L. Manatt, H. A. Day, R. V.
Hodges, P. A. Kroon, D. A. Redfield, T. L. Rold and D. E.
Williamson, J. Org. Chem., 1973, 38, 4109–4117.
We thank the EPSRC for a QUOTA award (to R. B.), for
financial support (EPSRC Grant no. EP/C542169/1) and
AstraZeneca for a CASE award (to R. B.)
20 For the synthesis of the core of obtusallenes II and IV, see: D. C.
Braddock, R. Bhuva, D. S. Millan, Y. Perez-Fuertes, C. A.
´
Roberts, R. N. Sheppard, S. Solanki, E. S. E. Stokes and A. J.
P. White, Org. Lett., 2007, 9, 445–448.
Notes and references
1 K. Murai, in Comprehensive Natural Product Chemistry, ed. D. H.
R. Barton, O. Meth-Cohn and K. Nakanishi, 1999, vol. 1,
pp. 303–324.
21 For the structural reassignment of obtusallenes V, VI and VII by
GIAO-based density functional prediction, see: D. C. Braddock
and H. S. Rzepa, J. Nat. Prod., 2008, in press.
ꢁc
This journal is The Royal Society of Chemistry 2008
Chem. Commun., 2008, 1419–1421 | 1421